home / stock / orgo / orgo news


ORGO News and Press, Organogenesis Holdings Inc. From 02/29/24

Stock Information

Company Name: Organogenesis Holdings Inc.
Stock Symbol: ORGO
Market: NASDAQ

Menu

ORGO ORGO Quote ORGO Short ORGO News ORGO Articles ORGO Message Board
Get ORGO Alerts

News, Short Squeeze, Breakout and More Instantly...

ORGO - Organogenesis (ORGO) Q4 2023 Earnings Call Transcript

2024-02-29 21:00:14 ET Image source: The Motley Fool. Organogenesis (NASDAQ: ORGO) Q4 2023 Earnings Call Feb 29, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis (ORGO) Q4 2023 Earnings Call Transcript

ORGO - Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

CANTON, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today re...

ORGO - Expected US Company Earnings on Thursday, February 29th, 2024

Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...

ORGO - Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

CANTON, Mass., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...

ORGO - Cantor starts Organogenesis at overweight, cites differentiated portfolio

2024-02-08 19:05:53 ET More on Organogenesis Holdings Seeking Alpha’s Quant Rating on Organogenesis Holdings Historical earnings data for Organogenesis Holdings Financial information for Organogenesis Holdings Read the full article on Seeking Alpha ...

ORGO - Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024

CANTON, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...

ORGO - Biolase, Adaptive Biotechnologies among healthcare movers

2023-11-10 10:00:06 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom September Labor Report Preview: Full Employ...

ORGO - DOCS, ORGO and GBIO are among pre market gainers

2023-11-10 08:17:54 ET Motus GI Holdings  ( MOTS ) +64% Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu EVS Gastro. Direct Digital Holdings ( DRCT ) +44% Digital Holdings, Inc. (DRCT) - FORM 10-Q | Quarterly Report. AVITA Medical ( RCEL ...

ORGO - Organogenesis Holdings, Inc. (ORGO) Q3 2023 Earnings Call Transcript

2023-11-09 22:16:02 ET Organogenesis Holdings, Inc. (ORGO) Q3 2023 Earnings Conference Call November 09, 2023, 05:00 PM EST Company Participants Gary Gillheeney - President, CEO & Chair David Francisco - CFO Conference Call Participants Ryan Zimmerman...

ORGO - Organogenesis (ORGO) Q3 2023 Earnings Call Transcript

2023-11-09 19:45:14 ET Image source: The Motley Fool. Organogenesis (NASDAQ: ORGO) Q3 2023 Earnings Call Nov 09, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis (ORGO) Q3 2023 Earnings Call Transcript

Previous 10 Next 10